Miconazolnitraat Leidapharm (Miconazole Nitrate)

Miconazole nitrate is used topically to treat fungal skin conditions within the dermatophyte and Candida infection families.

• Athlete’s foot (tinea pedis): reduces itching and clears the infection on the feet.
• Jock itch (tinea cruris): alleviates redness and eliminates the fungal growth in the groin area.
• Ringworm (tinea corporis): promotes healing of circular skin lesions caused by dermatophytes.
• Cutaneous candidiasis: eradicates Candida species from skin folds and mucocutaneous surfaces.

• Miconazole nitrate inhibits the fungal enzyme lanosterol 14α‑demethylase, a cytochrome P450 isoform essential for converting lanosterol to ergosterol. By blocking ergosterol synthesis, the drug disrupts the integrity of the fungal cell membrane, leading to increased permeability, leakage of intracellular contents and ultimately fungal cell death. The effect is localized to the applied skin area. Because the compound remains on the surface, systemic absorption is minimal, limiting systemic exposure.

Topical application of miconazole nitrate may be associated with local skin reactions and, rarely, systemic adverse events.

Common Side Effects

• Burning sensation: mild transient heat at the application site.
• Itching: occasional pruritus around the treated area.
• Redness: mild erythema that resolves with continued use.
• Dryness or peeling: slight flaking of the skin.

Serious or Rare Side Effects

• Severe allergic reaction: swelling, hives or difficulty breathing requiring immediate medical attention.
• Contact dermatitis: intense rash, blistering or swelling beyond the treated area.
• Systemic toxicity: rare hepatic or hematologic abnormalities reported after extensive use.

When using Miconazolnitraat Leidapharm, consider the following precautions to ensure safe and effective treatment.

• Avoid use on broken or inflamed skin: apply only to intact epidermis.
• Do not cover treated area with occlusive dressings unless directed: may increase absorption.
• Limit duration of therapy: follow prescriber recommendations to reduce resistance risk.
• Discontinue if signs of allergic reaction appear: seek medical advice promptly.
• Pregnancy and lactation: consult healthcare professional before use, as safety data are limited.
• Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Miconazole nitrate can interact with other substances; awareness of these interactions helps avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Concurrent use with systemic azole antifungals: may increase systemic exposure and risk of hepatotoxicity.
• Co‑application with topical corticosteroids: can diminish antifungal effectiveness.

Moderate Interactions (Monitor Closely)

• Use with CYP450 inhibitors (e.g., ketoconazole, erythromycin): may modestly raise local drug levels.
• Application alongside other topical agents (antibiotics, antiseptics): monitor for skin irritation.
• Use with alcohol‑based hand sanitizers: may cause transient burning sensation.